Compounded Semaglutide vs Wegovy 2026: $99/mo vs $1,400/mo (Same Active Ingredient)
Honest comparison of compounded semaglutide vs Wegovy in 2026 — same active ingredient, dramatically different price. When to choose each, and how to save 90%+ legitimately.
Quick Verdict
Compounded semaglutide and Wegovy contain the same active ingredient (semaglutide). The difference is regulatory pathway: Wegovy is FDA brand-name; compounded semaglutide is FDA 503A/503B pathway. Both are legitimate.
Cost difference: Trimi's compounded semaglutide is $99/mo flat; cash-pay Wegovy is $1,200-$1,400/mo retail or ~$499/mo via NovoCare. Annual savings switching to compounded: $4,800-$15,612/year.
About this comparison
Both compounded semaglutide and Wegovy are legitimate medical products. Wegovy is FDA-approved as a brand-name medication by Novo Nordisk; compounded semaglutide is dispensed by FDA 503A/503B pharmacies under federal and state oversight. Pricing is based on publicly listed rates as of May 2026. This article is informational and not medical advice.
More on Compounded vs Brand-Name Semaglutide
Compounded Semaglutide vs Brand Name
General comparison covering Wegovy and Ozempic.
Wegovy Cost Without Insurance 2026
Cash-pay pricing tiers and alternatives.
Cheapest Semaglutide Online 2026
Lowest-cost path to semaglutide treatment.
Compounded Tirzepatide vs Zepbound 2026
Same comparison for tirzepatide.
Side-by-Side Comparison
| Factor | Wegovy | Compounded Semaglutide (Trimi) |
|---|---|---|
| Active ingredient | Semaglutide | Semaglutide (identical) |
| Regulatory pathway | FDA brand-name approval | FDA 503A / 503B compounding |
| Manufacturer | Novo Nordisk (FDA-approved facilities) | Licensed 503A/503B compounding pharmacy |
| Cash price (monthly) | $1,200-$1,400/mo retail; ~$499/mo NovoCare | $99/mo flat |
| Annual cash cost | $5,988-$16,800/yr | $1,188/yr |
| Insurance coverage | Variable (employer-dependent for weight loss) | N/A — cash-pay model |
| Delivery system | Pre-filled pens (or vials via NovoCare) | Vials with syringes (typically) |
| Provider model | Standard prescription via PCP/specialist | Telehealth provider with 10-15 min intake |
| Speed: prescription → medication | Same-day pickup at pharmacy | 5-10 days from intake to delivery |
The Math: 12-Month Cost Comparison
For a typical patient on semaglutide for 12 months:
Wegovy (retail)
$14,400-$16,800
$1,200-$1,400/mo × 12
Wegovy (NovoCare)
$5,988
~$499/mo × 12 (vials)
Trimi (compounded)
$1,188
$99/mo × 12 (flat)
Annual savings switching from Wegovy retail to compounded: $13,212-$15,612
Annual savings switching from NovoCare to compounded: $4,800
Where Wegovy Wins
Wegovy's genuine strengths over compounded semaglutide:
- FDA brand-name approval: Full pharmacokinetic studies, uniform manufacturing in Novo Nordisk facilities, complete prescribing information for weight management
- Pre-filled pen delivery: Simpler administration than vials + syringes (especially for needle-averse patients) — though NovoCare uses vials
- Insurance coverage path: Some employer plans cover Wegovy; compounded options aren't typically covered
- Same-day pharmacy access: Pick up at CVS/Walgreens immediately after prescription; compounded ships in 5-10 days
- Established product reputation: Patients and providers familiar with the brand
- Long track record: Semaglutide has been on the market longer than tirzepatide; Wegovy specifically has years of post-market data
Where Compounded Semaglutide Wins
Compounded semaglutide's genuine strengths over Wegovy:
- Cost: 92-93% cheaper than retail; 80% cheaper than NovoCare — $4,800-$15,612 saved annually
- Same active ingredient: Semaglutide is the molecule responsible for weight loss — both products contain it identically
- Telehealth convenience: 10-15 minute online intake from home; no in-person visits, no pharmacy queue
- Provider specialization: Compounded telehealth providers (like Trimi) focus exclusively on GLP-1 medications
- No insurance hoops: Flat pricing bypasses prior authorization, formulary games, copay surprises
- Predictable monthly cost: $99/month every month, no insurance changes affecting your treatment
When Wegovy Is the Right Choice
Wegovy is the better pick if:
- Your insurance covers Wegovy and the copay is $50/month or less
- You qualify for the Wegovy Savings Card and the discounted price beats compounded options
- You strongly prefer pen delivery over vial + syringe
- You want same-day pharmacy pickup (compounded ships in 5-10 days)
- You have specific medical reasons where uniform brand-name manufacturing matters
When Compounded Semaglutide Is the Right Choice
Compounded semaglutide is the better pick if:
- You're paying cash and don't have insurance coverage for Wegovy
- You don't qualify for the Wegovy Savings Card or NovoCare's self-pay program
- Cost is a meaningful factor — $13,200+/year savings is substantial over multiple years of treatment
- You prefer telehealth convenience (online intake, home delivery)
- You're comfortable with vials + syringes for administration
- You're comfortable with the FDA 503A/503B compounding pathway as legitimate medical option
How to Switch from Wegovy to Compounded Semaglutide
- 1Don't run out of Wegovy first: Time the transition so you have a 1-2 week supply in hand when starting Trimi's intake.
- 2Submit Trimi's intake: 10-15 minute online questionnaire, including your current Wegovy dose, titration history, and any side effects.
- 3Provider review: Trimi's licensed clinician reviews your history (24-48 hours) and prescribes compounded semaglutide at your existing dose.
- 4Medication ships: 3-5 business days to your home from a licensed compounding pharmacy.
- 5Continue treatment: Weekly injection at the same dose. Your titration schedule, weight loss progression, and side effect profile should remain consistent.
Frequently Asked Questions
Is compounded semaglutide the same drug as Wegovy?
Yes — both contain semaglutide as the active ingredient. The molecule is identical. The difference is the regulatory pathway: Wegovy is FDA-approved as a brand-name medication manufactured by Novo Nordisk; compounded semaglutide is dispensed by FDA 503A or 503B compounding pharmacies. Same drug, different production.
How much cheaper is compounded semaglutide vs Wegovy?
Dramatically cheaper. Compounded semaglutide via Trimi is $99/month flat ($1,188/year). Wegovy at retail pharmacy is $1,200-$1,400/month ($14,400-$16,800/year). NovoCare's self-pay program is ~$499/month ($5,988/year). Trimi saves 80-93% versus brand-name pricing.
Is compounded semaglutide as effective as Wegovy?
Real-world outcomes data (when available) suggests similar weight loss results. The active ingredient is identical, so effectiveness should be comparable for most patients. Brand-name Wegovy has the advantage of pharmacokinetic studies and uniform manufacturing controls. Compounded versions from licensed 503A/503B pharmacies use the same active ingredient with rigorous quality testing.
Is compounded semaglutide legal?
Yes. Compounded semaglutide is dispensed under FDA 503A and 503B pathways — established compounding regulations that have existed for decades. During FDA's semaglutide shortage declaration (2022-2024), compounding was explicitly permitted to ensure patient access. Outside of shortage status, FDA 503A and 503B pathways allow compounding for clinically necessary patient-specific prescriptions and bulk compounding for healthcare facilities.
Why does Wegovy cost so much more?
Brand-name pharmaceutical pricing reflects R&D recovery, FDA-approved manufacturing facilities, marketing investment, and what the U.S. healthcare market will bear during patent protection. Compounded versions use the same active ingredient but bypass brand-name marketing, sales force, and patent-recovery pricing.
Can I switch from Wegovy to compounded semaglutide?
Yes — many patients do, primarily for cost reasons. The active ingredient is the same, so dose and titration schedule transfer directly. Request your prescription history from your Wegovy prescriber, then submit Trimi's 10-15 minute online intake. Trimi providers can continue treatment at your current dose.
Is Wegovy or Ozempic the right comparison?
Both Wegovy and Ozempic contain semaglutide. Wegovy is FDA-approved for weight loss; Ozempic is FDA-approved for type 2 diabetes. The active ingredient is identical. If you're using either brand for weight loss and looking for compounded alternatives, the comparison applies equally — compounded semaglutide is the same molecule at much lower cost.
Disclaimer: Wegovy is a registered trademark of Novo Nordisk. Trimi is an unaffiliated telehealth provider offering compounded semaglutide. Both are legitimate medical products under different regulatory pathways. Pricing is current as of May 2026 and subject to change. This article is informational and not medical advice. Always consult a licensed clinician about whether semaglutide (brand-name or compounded) is appropriate for your individual health situation.